BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioNTech's total debt was €301.50M at Dec 31, 2021. For fiscal 2021 it was €301.50M, up 25.6% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | €301.50M | +25.6% |
| FY2020 | Dec 31, 2020 | €240.10M | +223.5% |
| FY2019 | Dec 31, 2019 | €74.21M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | €301.50M | – |
| Q4 FY2020 | Dec 31, 2020 | €240.10M | – |
| Q4 FY2019 | Dec 31, 2019 | €74.21M | – |
See a number that looks wrong?